Related Experiment Video
Updated: Jul 29, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Acute nonlymphocytic leukemia in adults. When diagnosis and pretreatment assessment can't wait
Abstract:
Because adults with acute nonlymphocytic leukemia (ANLL) frequently present with vague complaints and nonspecific findings, it is usually the primary care physician who sees them first. The initial clinical evaluation of such patients should include making the diagnosis, beginning to characterize the leukemia, and assessing the overall medical condition of the patient. All phases of this evaluation should be completed with a sense of urgency because immediate medical intervention is often necessary. Prompt assessment and institution of therapy take on added importance now that effective chemotherapy is available. Currently, a large majority of patients with ANLL respond to treatment and 15% to 20% are probably cured. With the use of various clinical and laboratory studies, the physician can rapidly confirm a suspected diagnosis of ANLL and systematically evaluate the patient's condition prior to arranging for appropriate treatment.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018